In the immunohistochemical analyses, FOXM1 was overexpressed in 49% of the primary melanomas and 67% of the metastatic melanomas, whereas a markedly lower rate of expression was observed in the benign melanocytic nevi. The gene discussed is FOXM1; the disease is melanoma.